CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin ... - MarketWatch

CRESTOR Demonstrates Dramatic CV Risk Reduction in a Large Statin ... MarketWatch - Nov 9, 2008 The JUPITER trial confirmed that CRESTOR dramatically reduces LDL-C cholesterol levels and has now demonstrated a nearly 50% reduction in the risk of heart ...

Merck's 2008: The Year That Wasn't - Trading Markets (press release)

Merck's 2008: The Year That Wasn't Trading Markets (press release), CA - Nov 19, 2008 Cordaptive is a combination of Merck-developed extended-release Niacin and Laropiprant. However, the drug was approved in Europe in May. ...

Ghana: Volta Basin Problems, Whose Headache? (1) - AllAfrica.com

Ghana: Volta Basin Problems, Whose Headache? (1) AllAfrica.com, Washington - Nov 14, 2008 The National Heart and Lung Institute of the United States (NHLI) suggest oysters as an ideal food for inclusion in low-cholesterol diets. ...